NSE: EPL | BSE: 500135

Mid-range Performer

Download real time

201.30 6.33 (3.25%)

30.56% Fall from 52W High

205.2K NSE+BSE Volume

NSE 24 Apr, 2025 10:01 AM (IST)

6,432.9

Market Cap

Market Runner Up

1.0

Beta 1Year

Average volatility

EPL Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for EPL, BSE:500135 EPL Ltd.

EPL Ltd.

28 Feb 2019

201.30

3.25%

Essel Propack posted 16.7% YoY growth in revenue in Q3FY19 supported by broad-based growth across geographies. AMESA region, largest contributor to overall sales, grew by 13.5% YoY in Q3FY19 led by robust revenue growth in Egypt (up by 54.8% YoY) in both oral and non-oral care categories. Egypt nonoral care category revenue composition improved by 4.9 percentage point (pp) YoY. India revenues grew just 8.9% YoY in Q3FY19 impacted by lower pharma segment volumes due to change in pharma regulations. However, with the issues being addressed by the industry, we expect India business to witness an improved performance going ahead given strong order pipeline coupled with ramp-up of Assam facility and commencement of production of a new laminator in December 2018. The new facility will increase the lamination capacity by 25 million square metres to 80 million square metres per annum....

EPL Ltd. is trading above its 30 day SMA of 197.6

EPL Ltd.

19 Feb 2019

201.30

3.25%

We met Essel Propack's (ESEL) management to understand the traction in its non-oral care...

Hold: EPL Ltd.

Emkay

We met Essel Propack's (ESEL) management to understand the traction in its non-oral care business and the progress on commercial orders from European customers. management's commentary. We believe that its investments in non-oral care customers in Europe should pay off gradually as trials get translated into commercial orders. growth. Europe should ramp up faster given with new facility in Russia and the shift of nonoral care customers to ESEL's laminated packaging solutions. ESEL has recovered Rs650m from a related party out of the total of Rs1.1bn as of Mar18. Management said that the company will receive the balance by Mar-19. The proceeds will be utilized to pay off debt. We maintain our Hold rating with a revised TP of Rs120, valuing it at 15x FY21E EPS. The...

EPL Ltd. is trading above its 30 day SMA of 197.6

EPL Ltd.

25 Jan 2019

201.30

3.25%

Essel Propack Ltd

Hold: EPL Ltd.

Target

ICICI Securities Limited

Essel's consolidated sales growth of ~17% YoY was led by strong performance of all regions, largely on a lower base wherein performance of Amesa and Europe region was hurt by GST led transition (in India) and lower volume offtake by key customer in Europe. In Q3FY19, revenue contribution of non-oral category to consolidated sales increased from 41.3% in Q3FY18 to 43.5% in Q3FY19. According to management, Amesa region (contributes 38% to topline) will record healthy performance, going forward, as...

EPL Ltd. has lost -22.96% in the last 6 Months

EPL Ltd.

21 Nov 2018

201.30

3.25%

ESSEL PACKAGINGS

Hold: EPL Ltd.

Recommendation Target

Geojit BNP Paribas

Revenue growth was restricted to 7% YoY in Q2FY19 as strong performance in EAP, Americas and Europe region was offset by weak sales in AMESA. EAP revenue grew by 16.6% in Q2FY19 led by increased contribution from non-oral care category while Europe revenue rose by 12% YoY led by strong growth in Poland. AMESA region disappointed with 1.2% YoY decline in revenue in Q2FY19 mainly due to weak...

EPL Ltd. has an average target of 318.75 from 4 brokers.

EPL Ltd.

02 Nov 2018

201.30

3.25%

Essel Propack Ltd

Hold: EPL Ltd.

Target

ICICI Securities Limited

On a consolidated basis, the company witnessed sales growth of 6.8% YoY to | 683.5 crore (vs. I-direct estimate: | 700.1 crore) mainly led by double digit growth in EAP, Europe & Americas region. Revenues from the AMESA witnessed de-growth of 1.2% to | 233.7 crore. Europe revenues grew 11.8% to | 147.9 crore. EAP & Americans region witnessed growth of 16.6% & 11.2% to | 184.7 crore and | 143.5 crore respectively. Within Amesa, India business adversely impacted by low client offtake, pharma regulations and...

EPL Ltd. is trading below its 50 day SMA of 210.1

EPL Ltd.

30 Jul 2018

201.30

3.25%

Essel Propack Ltd

Hold: EPL Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Essel Propack's Q1FY19 performances were largely driven by EAP & America regions with topline growth of ~18% YoY and 26%, respectively, led by a recovery in demand from existing clients. However, Amesa and European region's performance was marred by lower-than-expected volume offtake by key customers (Indian business hit by change in packaging norms under the pharma category coupled with lower offtake by key customers). Change in...

EPL Ltd. has lost -22.96% in the last 6 Months

EPL Ltd.

18 Jul 2018

201.30

3.25%

Essel Propack Ltd

Buy: EPL Ltd.

CD Equisearch

EPL Ltd. is trading below its 50 day SMA of 210.1

EPL Ltd.

20 Jun 2018

201.30

3.25%

Essel Propack Ltd

Hold: EPL Ltd.

ICICI Securities Limited

Essel Propack Ltd (EPL) made an announcement of bonus shares on April 26, 2018. The ratio was one bonus share for every one existing equity share i.e. 1:1. The record date for the same was May 18, 2018 while the ex-date for the same is today i.e. June 20, 2018. Consequently, EPL share price, as per yesterday's closing price, has dropped to | 123/share from |246/share....

EPL Ltd. is trading above its 30 day SMA of 197.6

EPL Ltd.

12 Jun 2018

201.30

3.25%

Result Update:Essel Propack

Neutral: EPL Ltd.

Axis Direct

Essel Propack (Essel) in 4QFY18 posted revenues of Rs 628 Cr. due to continued GST related impact on Indian operations; however Europe showed signs of recovery led by Germany.

EPL Ltd. is trading above its 30 day SMA of 197.6

EPL Ltd.

24 May 2018, 12:00AM

201.30

3.25%

ESSEL PACKAGINGS

Buy: EPL Ltd.

Geojit Research

Americas revenue grew by 6.5% in CC terms in Q4FY18 supported by strong performance of USA (up 8.4%) and Mexico (up 17.2%). EBITDA margin contracted by ~107 bps YoY to 18.5% as strong 240 bps YoY expansion in EBITDA margin in Americas region was marred by 60 bps decline in EBITDA margin in EAP and weak operating performance in Europe. We lower our revenue and adj.PAT estimates for FY19E/20E by 5%/6% and 11%/14% to factor in weak India sales and delay in rebound of European performance. However, we remain positive on the stock on the back of expected recovery in India...

EPL Ltd. has lost -22.96% in the last 6 Months

Is Essel Propack Ltd. worth buying?

243 Votes:

Buy 86.01%

Sell 9.05%

Hold 4.94%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf